Chondrocalcinosis of the Knee and the Risk of Osteoarthritis Progression: Data From the Knee and Hip Osteoarthritis Long‐term Assessment Cohort

To assess the impact of knee chondrocalcinosis (CC) on the 5‐year risk of joint replacement and disease progression in patients with knee osteoarthritis (OA).

[1]  G. Mccarthy,et al.  Calcium crystal deposition diseases — beyond gout , 2018, Nature Reviews Rheumatology.

[2]  T. Smith,et al.  Systematic review and meta-analysis of the reliability and discriminative validity of cartilage compositional MRI in knee osteoarthritis. , 2018, Osteoarthritis and cartilage.

[3]  Woojin Kim,et al.  Association of Chondrocalcinosis in Knee Joints With Pain and Synovitis: Data From the Osteoarthritis Initiative , 2017, Arthritis care & research.

[4]  Christie M. Bartels,et al.  Calcium Pyrophosphate Deposition Disease and Associated Medical Comorbidities: A National Cross‐Sectional Study of US Veterans , 2017, Arthritis care & research.

[5]  M. Nevitt,et al.  Evaluation of Chondrocalcinosis and Associated Knee Joint Degeneration Using MR Imaging: Data from the Osteoarthritis Initiative , 2017, European Radiology.

[6]  J. Bertrand,et al.  Articular cartilage calcification of the hip and knee is highly prevalent, independent of age but associated with histological osteoarthritis: evidence for a systemic disorder. , 2016, Osteoarthritis and cartilage.

[7]  A. Abhishek.  Calcium pyrophosphate deposition disease: a review of epidemiologic findings , 2016, Current opinion in rheumatology.

[8]  G. Filippou,et al.  Diagnostic accuracy of ultrasound, conventional radiography and synovial fluid analysis in the diagnosis of calcium pyrophosphate dihydrate crystal deposition disease. , 2016, Clinical and experimental rheumatology.

[9]  K. Muir,et al.  Does Chondrocalcinosis Associate With a Distinct Radiographic Phenotype of Osteoarthritis in Knees and Hips? A Case–Control Study , 2016, Arthritis care & research.

[10]  F. Lioté,et al.  Clinical implications of pathogenic calcium crystals , 2014, Current opinion in rheumatology.

[11]  K. Muir,et al.  Association between low cortical bone mineral density, soft-tissue calcification, vascular calcification and chondrocalcinosis: a case-control study , 2013, Annals of the rheumatic diseases.

[12]  K. Muir,et al.  Evidence of a Systemic Predisposition to Chondrocalcinosis and Association Between Chondrocalcinosis and Osteoarthritis at Distant Joints: A Cross‐Sectional Study , 2013, Arthritis care & research.

[13]  Daniel Prieto-Alhambra,et al.  Incidence and risk factors for clinically diagnosed knee, hip and hand osteoarthritis: influences of age, gender and osteoarthritis affecting other joints , 2013, Annals of the rheumatic diseases.

[14]  W. Grassi,et al.  Extent and distribution of CPP deposits in patients affected by calcium pyrophosphate dihydrate deposition disease: an ultrasonographic study , 2013, Annals of the rheumatic diseases.

[15]  F. Guillemin,et al.  The KHOALA cohort of knee and hip osteoarthritis in France. , 2012, Joint, bone, spine : revue du rhumatisme.

[16]  C. Bombardier,et al.  Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational study , 2012, Arthritis care & research.

[17]  K. Muir,et al.  Chondrocalcinosis is common in the absence of knee involvement , 2012, Arthritis Research & Therapy.

[18]  M. Nevitt,et al.  Progression of osteoarthritis as a state of inertia , 2012, Annals of the rheumatic diseases.

[19]  F. Guillemin,et al.  Prevalence of symptomatic hip and knee osteoarthritis: a two-phase population-based survey. , 2011, Osteoarthritis and cartilage.

[20]  Issa J Dahabreh,et al.  Index event bias as an explanation for the paradoxes of recurrence risk research. , 2011, JAMA.

[21]  F. Perez-Ruiz,et al.  European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis , 2011, Annals of the rheumatic diseases.

[22]  S. Cole,et al.  Illustrating bias due to conditioning on a collider. , 2010, International journal of epidemiology.

[23]  H. Schumacher,et al.  Does acute synovitis (pseudogout) occur in patients with chronic pyrophosphate arthropathy (pseudo-osteoarthritis)? , 2009, Clinical and experimental rheumatology.

[24]  C. Lohmann,et al.  Calcification of articular cartilage in human osteoarthritis. , 2009, Arthritis and rheumatism.

[25]  P Tugwell,et al.  OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. , 2008, Osteoarthritis and cartilage.

[26]  R. Terkeltaub,et al.  Calcification of human articular knee cartilage is primarily an effect of aging rather than osteoarthritis. , 2007, Osteoarthritis and cartilage.

[27]  V. Wilairatana,et al.  Comparison of characteristics of patients with and without calcium pyrophosphate dihydrate crystal deposition disease who underwent total knee replacement surgery for osteoarthritis. , 2007, Osteoarthritis and cartilage.

[28]  R. Terkeltaub,et al.  Lack of association between chondrocalcinosis and increased risk of cartilage loss in knees with osteoarthritis: results of two prospective longitudinal magnetic resonance imaging studies. , 2006, Arthritis and rheumatism.

[29]  K. Muir,et al.  UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte , 2003, Annals of the rheumatic diseases.

[30]  R. Glynn,et al.  Musculoskeletal disease research: should we analyze the joint or the person? , 1996, The Journal of rheumatology.

[31]  M. Pladevall,et al.  Analysis of the association between chondrocalcinosis and osteoarthritis: a community based study. , 1996, Annals of the rheumatic diseases.

[32]  A. Jones,et al.  Radiographic patterns and associations of osteoarthritis of the knee in patients referred to hospital. , 1993, Annals of the rheumatic diseases.

[33]  W. Murphy,et al.  The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. , 1990, Arthritis and rheumatism.

[34]  C. Goldsmith,et al.  Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. , 1988, The Journal of rheumatology.

[35]  R. Moskowitz,et al.  Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. , 1986, Arthritis and rheumatism.

[36]  J. Kellgren,et al.  Radiological Assessment of Osteo-Arthrosis , 1957, Annals of the rheumatic diseases.

[37]  R. Panush.  The impact of knee and hip chondrocalcinosis on disability in older people: the ProVA Study from northeastern Italy , 2012 .

[38]  H. Schumacher,et al.  Synovial fluid features and their relations to osteoarthritis severity: new findings from sequential studies. , 2003, Osteoarthritis and cartilage.

[39]  J. Gerster,et al.  Local Deposition of Calcium Pyrophosphate Crystals in Evolution of Knee Osteoarthritis , 2001, Clinical Rheumatology.

[40]  T D Cooke,et al.  The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. , 1991, Arthritis and rheumatism.